Published in Int J Neurosci on January 01, 1979
Drug management of pain in cancer patients. Can Med Assoc J (1985) 1.05
Treatment of peripheral neuropathies. J Neurol Neurosurg Psychiatry (1985) 0.96
Paroxetine for somatic pain associated with physical illness: a review. Prim Care Companion J Clin Psychiatry (2006) 0.78
Antinociceptive action of tricyclic antidepressant drugs in the rat. Anesth Prog (1990) 0.76
The use of the Morris Water Maze in the study of memory and learning. Int J Neurosci (1989) 2.28
Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am J Clin Nutr (1989) 1.18
The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol (Noisy-le-grand) (2000) 1.14
Learning is improved by a soybean oil diet in rats. Life Sci (1986) 1.09
Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine. Nature (1972) 1.02
Sinistrad mirror writing and reading after brain concussion in a bi-systemic (oriento-occidental) polyglot. Cortex (1976) 1.02
Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol Biochem Behav (1986) 0.98
Peptides and thermoregulation. Neurosci Biobehav Rev (1980) 0.97
Anterior horn cell changes in a case of neurolathyrism. Acta Neuropathol (1976) 0.96
The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev (2007) 0.96
In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: indications for interactions between hippocampal-cortical cholesterol and learning. Life Sci (1986) 0.95
Ethyl chloride sniffing and cerebellar dysfunction (case report). Isr Ann Psychiatr Relat Discip (1979) 0.94
Changes in the cholesterol level, cholesterol-to-phospholipid mole ratio, and membrane lipid microviscosity in rat brain induced by age and a plant oil mixture. Biochem Pharmacol (1985) 0.94
Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci (1996) 0.93
Effect of diphenylhydantoin on the reproductive function of the male rat. J Neurol Neurosurg Psychiatry (1978) 0.92
Motor lesions in herpes zoster. Incidence and special features. Eur Neurol (1975) 0.90
Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified alpha-linolenic and linoleic acids: determination of the optimal omega 3-to-omega 6 ratio. Proc Natl Acad Sci U S A (1993) 0.89
Decrease of serum iron in acutely psychotic schizophrenic patients. Int J Neurosci (1994) 0.88
Torsion dystonia in Israel. Ann Neurol (1980) 0.87
Modification of cytokine secretion following mild emotional stimuli. Neuroreport (1995) 0.87
Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats. Eur J Pharmacol (1981) 0.86
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand (1988) 0.86
Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology (2009) 0.86
The effects of D-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci I (1972) 0.85
Moderate nonketotic hyperglycemia--a cause of focal epilepsy. Report of two cases and review of literature. Eur Neurol (1977) 0.84
Nutritional deficiencies in learning and cognition. J Pediatr Gastroenterol Nutr (2006) 0.84
Acute and repeated gestational stress affect offspring learning and activity in rats. Physiol Behav (1988) 0.84
Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine. J Pharmacol Exp Ther (1974) 0.84
Brain iron-deficiency causes reduced learning capacity in rats. Pharmacol Biochem Behav (1986) 0.84
Personality type, life events and sudden cerebrovascular attack. Int J Neurosci (1981) 0.84
Fatty acids and brain peptides. Peptides (1998) 0.83
[Attitudes of family physicians to alternative medicine]. Harefuah (1998) 0.83
Selective alteration in blood-brain barrier and insulin transport in iron-deficient rats. J Neurochem (1988) 0.83
Ophthalmoplegic migraine: amelioration by Flufenamic acid, a prostaglandin inhibitor. Ophthalmologica (1977) 0.83
Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol (1994) 0.82
Effects of essential fatty acids in iron deficient and sleep-disturbed attention deficit hyperactivity disorder (ADHD) children. Eur J Clin Nutr (2011) 0.82
Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation. Neurology (2003) 0.82
Disorders of verbal expression in parkinsonism. Adv Neurol (1984) 0.82
Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene. Neurology (1999) 0.82
Skeletal findings in human neutrolethyrism. Is there a human osteolathyrism? Eur Neurol (1980) 0.82
Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study. J Neural Transm (1978) 0.81
Brain iron and dopamine receptor function. Adv Biochem Psychopharmacol (1983) 0.80
Human neurolathyrism, a follow-up study of 200 patients. Part I: Clinical investigation. Schweiz Arch Neurol Neurochir Psychiatr (1981) 0.80
L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients. Gerontology (1977) 0.80
Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology (2000) 0.80
Physiological evidence (hypothermia) for central effects of beta-blocker agents. Int J Neurosci (1981) 0.80
Iron deficiency induces reversal of dopamine dependent circadian cycles: differential response to d-amphetamine and TRH. Peptides (1986) 0.79
Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscul Disord (1997) 0.79
Sub-acute thyroiditis complicated by chorea minor. Bull Los Angeles Neurol Soc (1971) 0.79
Penetrating injuries of the parapharyngeal space. Arch Otolaryngol (1972) 0.79
Thermoregulatory and locomotor effects of DSIP: paradoxical interaction with d-amphetamine. Pharmacol Biochem Behav (1980) 0.79
Fatty acid mixture counters stress changes in cortisol, cholesterol, and impair learning. Int J Neurosci (2000) 0.79
Onset and progression of disease in familial and sporadic Parkinson's disease. Am J Med Genet A (2004) 0.78
Alien hand sign in Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2000) 0.78
Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates. Adv Neurol (1984) 0.78
A comparison of dopamine agonists and catechol-O-methyltransferase inhibitors in Parkinson's disease. Clin Neuropharmacol (2001) 0.78
Painful ophthalmoplegia: the Tolosa-Hunt syndrome. Eur Neurol (1979) 0.78
EEG sleep study in parkinsonian patients under bromocryptine treatment. Eur Neurol (1978) 0.78
Learning-induced changes in brain membrane cholesterol and fluidity: implications for brain aging. Int J Neurosci (1985) 0.78
Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine. Eur J Pharmacol (1975) 0.78
Nutrients, brain biochemistry, and behavior: a possible role for the neuronal membrane. Int J Neurosci (1987) 0.77
Effects of dietary fats on learning, pain threshold, thermoregulation and motor activity in rats: interaction with the length of feeding period. Int J Neurosci (1987) 0.77
[Dextran-40 in nonhemorrhagic cerebrovascular accidents]. Harefuah (1981) 0.77
The facilitative effects of alpha-MSH and melanin on learning, thermoregulation, and pain in neonatal MSG-treated rats. Peptides (1991) 0.77
The effects of D-amphetamine on dopaminergic regulated mechanisms of physiological and behavioral thermoregulation. Curr Dev Psychopharmacol (1979) 0.77
Cognitive asymmetries after wakings from REM and NONREM sleep in right-handed females. Int J Neurosci (1984) 0.77
Acute mania and hemichorea. Clin Neuropharmacol (2001) 0.77
Skin smoothing effects of Dead Sea minerals: comparative profilometric evaluation of skin surface. Int J Cosmet Sci (1997) 0.77
Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system. Peptides (1982) 0.76
The control of blepharospasm by essential fatty acids. Neuropsychobiology (2000) 0.76
Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J Neurol Neurosurg Psychiatry (1977) 0.76
The increased opiate action of beta-endorphin in iron-deficient rats: the possible involvement of dopamine. Eur J Pharmacol (1984) 0.76
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. J Neural Transm (1979) 0.76
The role of iron in the basal ganglion. Adv Neurol (1990) 0.76
Effects of alpha-MSH, TRH and AVP on learning and memory, pain threshold, and motor activity: preliminary results. Int J Neurosci (1987) 0.76
Effects of DSIP, 5-HTP and serotonin on the lymphokine system: a preliminary study. Int J Neurosci (1987) 0.76
Parkin gene causing benign autosomal recessive juvenile parkinsonism. Neurology (2001) 0.76
Chronic lithium treatment and dopamine-mediated behavior. Biol Psychiatry (1980) 0.76
Effects of specific brain lesions on the thermal responses of rats to D-amphetamine. J Neurosci Res (1976) 0.75
The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system. Peptides (1985) 0.75
Weight loss in patients treated long-term with levodopa. Metabolic aspects. J Neurol Sci (1976) 0.75
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study. J Neurol (1978) 0.75
Platelet monoamine oxidase B activity and vitamin B12 in dementia. Biol Psychiatry (1994) 0.75
Effects of TRH and PS-24 on colonic temperature and motor activity of rats: possible role of dopamine. Peptides (1981) 0.75
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading. J Neural Transm (1979) 0.75
Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures. Peptides (1980) 0.75
Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case. Obstet Gynecol Surv (1977) 0.75
Platelet monoamine oxidase B activity in dementia. A 4-year follow-up. Dement Geriatr Cogn Disord (1998) 0.75
The prevention and treatment of migraine with an analgesic combination. Br J Clin Pract (1984) 0.75
Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine. Int J Neurosci (1980) 0.75
The circadian cycle effects of DSIP on colonic temperature, blood pressure, and heart rate in control and area postrema-lesioned rats. Int J Neurosci (1988) 0.75
Flufenamic acid in prostaglandin migraine. Int J Neurosci (1985) 0.75
Treatment of cervical headache with hypnosis, suggestive therapy, and relaxation techniques. Am J Clin Hypn (1985) 0.75
DSIP--a tool for investigating the sleep onset mechanism: a review. Int J Neurosci (1988) 0.75
The effects of DSIP on pain threshold during light and dark periods in rats are not naloxone-sensitive. Int J Neurosci (1987) 0.75